Vitamin D Intervention in Young Adults With Severe Childhood-onset Obesity
NCT ID: NCT02549326
Last Updated: 2015-09-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
42 participants
INTERVENTIONAL
2012-11-30
2013-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of the study was to evaluate differences in vitamin D metabolism between young adults with severe childhood-onset obesity and normal-weight controls. Half of the obese subjects and controls will receive placebo and the other half will receive vitamin D3 50 µg daily for 12 weeks.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Vitamin D Supplementation in Obese Children
NCT02956408
Effects of Vitamin D Supplementation in Obesity
NCT01037140
Vitamin D Supplementation in Vitamin D Deficient Obese Children During Weight-loss Program
NCT02828228
Vitamin D Supplementation to Obese Chinese Males
NCT01781169
Monthly Boluses Versus Daily Doses for Correcting Blood Vitamin D Deficit in Obese Children and Adolescents
NCT03516968
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Obese, placebo
Placebo daily for 12 weeks
Placebo
Obese, vitamin D
Vitamin D3 50 µg / daily for 12 weeks
vitamin D
Control, placebo
Placebo daily for 12 weeks
Placebo
Control, vitamin D
Vitamin D3 50 µg / daily for 12 weeks
vitamin D
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
vitamin D
Placebo
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* referral to the Children's Hospital, Helsinki University Hospital due to severe obesity
* at the age of 7 years lived in the greater Helsinki area
Exclusion Criteria
15 Years
25 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Helsinki University Central Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elisa Holmlund-Suila
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Helena Valta, MD PhD
Role: STUDY_DIRECTOR
Helsinki University Central Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
295/13/03/03/2012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.